Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Gains from Investment Securities (2016 - 2025)

Marimed (MRMD) has disclosed Gains from Investment Securities for 12 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 63.8% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 54.29% year-over-year, with the annual reading at $1.3 million for FY2025, 54.29% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $1.6 million at Marimed, up from -$3.2 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $11.8 million in Q2 2022, with the low at -$11.9 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is $434400.0, with a median of $392500.0 recorded in 2021.
  • Peak annual rise in Gains from Investment Securities hit 295450.0% in 2022, while the deepest fall reached 4059.0% in 2022.
  • Over 5 years, Gains from Investment Securities stood at -$17000.0 in 2021, then surged by 5711.76% to $954000.0 in 2022, then decreased by 2.94% to $926000.0 in 2023, then surged by 365.98% to $4.3 million in 2024, then tumbled by 63.8% to $1.6 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $1.6 million, -$3.2 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.